New Jersey Assembly Bill A656

New Jersey 2022-2023 Regular Session

• Introduced: 1/11/22
• Refer: 1/11/22

Caption

Requires State and county correctional facilities to offer inmates hepatitis B and hepatitis C testing.

Impact

The implementation of this bill is expected to have significant implications for state laws governing inmate health services. By integrating hepatitis testing into the intake process, the state is taking proactive steps to address public health concerns within the incarcerated population. This can help reduce the transmission of these diseases and provide better health care to those in custody. Moreover, it aligns with broader public health strategies aimed at managing communicable diseases in populations with higher risks, such as those who are incarcerated.

Summary

Assembly Bill A656 mandates that both state and county correctional facilities in New Jersey offer testing for hepatitis B and hepatitis C to inmates upon their entry into the correctional system. This initiative is aimed at improving public health outcomes by identifying individuals who may be carrying these viruses, which can lead to severe health complications if left untreated. Importantly, the bill specifies that while the offer for testing is mandatory, participation by inmates is not compulsory, providing them with an option to decline.

Contention

While the bill generally received support as a necessary health measure, there may be concerns around the adequacy of resources to implement such testing effectively within correctional facilities. Critics may argue about the financial implications of expanding health services in prisons, or question how the state will ensure that testing leads to adequate follow-up care for those who test positive. Additionally, there might be debates over the ethical considerations of providing health services in correctional systems and the autonomy of inmates regarding their health choices.